Our results could suggest that the monofunctional complex might act differently than cisplatin on components of the GDF15 signaling pathway to potentially prevent NSCLC proliferation; however, the precise target of the both platinum complexes on this signaling pathway are uncertain. This evidence concerns the gene GDF15 and non-small cell lung carcinoma.